Joint Statement on Federal Concerns About Psychotropic Medication Safety
March 21, 2025
March 21, 2025
ARLINGTON, Virginia, March 21 -- The American Psychiatric Association issued the following statement:
* * *
Joint Statement on Federal Concerns About Psychotropic Medication Safety
The safety and efficacy of traditional antidepressants, antipsychotics, and mood stabilizers (such as lithium and some anticonvulsants) and stimulant medications have been established through decades of rigorous research, randomized clinical trials, peer-reviewed studies, meta-an . . .
* * *
Joint Statement on Federal Concerns About Psychotropic Medication Safety
The safety and efficacy of traditional antidepressants, antipsychotics, and mood stabilizers (such as lithium and some anticonvulsants) and stimulant medications have been established through decades of rigorous research, randomized clinical trials, peer-reviewed studies, meta-an . . .